| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Werewolf Therapeutics, Inc. (HOWL) has 4 insiders with recent SEC Form 4 filings, including 0 buys and 31 sells. HOWL is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 4.78M | $1.68M | - | |
| 10% | 4.78M | $1.68M | - | |
| Dir | 377.2K | $132.4K | -173,515 | |
| 10% | 361.2K | $126.8K | -678,226 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 11, 2026 | Ra Capital Management, L.P.53 | 10% Owner | Sell | 678,226 | $0.37 | $253,568.65 | -3.9% | - | - | |
| Jun 8, 2026 | Evnin Luke55 | Director | Sell | 105,565 | $0.41 | $43,028.88 | -7.6% | - | - | |
| May 26, 2026 | Evnin Luke55 | Director | Sell | 191,762 | $0.45 | $86,560.29 | -7.1% | - | - | |
| May 20, 2026 | Evnin Luke55 | Director | Sell | 171,049 | $0.45 | $76,363.35 | -5.2% | - | - | |
| May 12, 2026 | Evnin Luke55 | Director | Sell | 407,574 | $0.69 | $280,210.26 | -10.0% | - | - | |
| May 4, 2026 | Evnin Luke55 | Director | Sell | 274,619 | $0.72 | $198,309.62 | -5.0% | - | - | |
| Apr 29, 2026 | Evnin Luke55 | Director | Sell | 205,911 | $0.75 | $154,525.47 | -3.3% | - | - | |
| Jan 16, 2026 | Evnin Luke55 | Director | Sell | 38,782 | $0.54 | $20,942.28 | -1.8% | - | - | |
| Jan 15, 2026 | Evnin Luke55 | Director | Sell | 111,227 | $0.56 | $61,787.17 | -1.6% | +54.1% | - | |
| Jan 12, 2026 | Evnin Luke55 | Director | Sell | 91,374 | $0.59 | $53,533.26 | -1.3% | +47.8% | - |